Shirai, Y., Saito, N., Uwagawa, T., Shiba, H., Horiuchi, T., Iwase, R., . . . Yanaga, K. (2018). Pomalidomide promotes chemosensitization of pancreatic cancer by inhibition of NF-κB. Oncotarget.
Stile di citazione ChicagoShirai, Yoshihiro, Nobuhiro Saito, Tadashi Uwagawa, Hiroaki Shiba, Takashi Horiuchi, Ryota Iwase, Koichiro Haruki, Toya Ohashi, e Katsuhiko Yanaga. "Pomalidomide Promotes Chemosensitization of Pancreatic Cancer By Inhibition of NF-κB." Oncotarget 2018.
Citazione MLAShirai, Yoshihiro, et al. "Pomalidomide Promotes Chemosensitization of Pancreatic Cancer By Inhibition of NF-κB." Oncotarget 2018.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.